Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.
El-Khoueiry AB, Trojan J, Meyer T, Yau T, Melero I, Kudo M, Hsu C, Kim TY, Choo SP, Kang YK, Yeo W, Chopra A, Soleymani S, Yao J, Neely J, Tschaika M, Welling TH, Sangro B.
El-Khoueiry AB, et al. Among authors: soleymani s.
Ann Oncol. 2024 Apr;35(4):381-391. doi: 10.1016/j.annonc.2023.12.008. Epub 2023 Dec 25.
Ann Oncol. 2024.
PMID: 38151184
Free article.
Clinical Trial.